Catheter Precision (VTAK) Liabilities from Discontinued Operations (2020)
Catheter Precision's (VTAK) quarterly Liabilities from Discontinued Operations came in at 2102000.0 in Q4 2020.
Catheter Precision (VTAK) Liabilities from Discontinued Operations (2020) Analysis & Trends
Catheter Precision (VTAK) has 1 years of Liabilities from Discontinued Operations data on file, last reported at 2102000.0 in Q4 2020.
- On a quarterly basis, Liabilities from Discontinued Operations changed N/A year-over-year to 2102000.0 in Q4 2020; TTM through Dec 2020 was 2102000.0, a N/A change from a year earlier, with the FY2020 full-year figure at 2102000.0, changed N/A from the prior year.
- Liabilities from Discontinued Operations for Q4 2020 stood at 2102000.0.
- Over the last five years, Liabilities from Discontinued Operations for VTAK reached as high as 2102000.0 in Q4 2020 and fell as low as 2102000.0 in Q4 2020.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - |
| 10 | Catheter Precision | 0.80 | -811,999.20 | 390,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2020 | 2.10 Mn |
| Dec 31, 2020 | 2.10 Mn |